Phase 1 Ocular Hypertension Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Pregabalin (PRG) ophthalmic solutions in patients diagnosed with Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Ocular Hypertension (OHT)
Tavo Biotherapeutics32 enrolled1 locationACTRN12625000766415
Recruiting
Phase 1
Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
GlaucomaOcular Hypertension
EyeD Pharma18 enrolled1 locationNCT07036510
Recruiting
Phase 1
Phase I study of a Latanoprost Ocular Implant for treatment of Open Angle Glaucoma or Ocular Hypertension.
Open Angle GlaucomaOcular Hypertension
PolyActiva Pty Ltd6 enrolled1 locationACTRN12621001718831